跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DL-alpha tocopheryl acetate
首页
药物
DL-alpha tocopheryl acetate
Approved
Small Molecule
DL-alpha tocopheryl acetate
(Mvi Pediatric, Natafort)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
相关疾病
共 4 项相关疾病
Degenerative Retinal Disorders
Eye degenerative disorder
Vitamin Deficiency
Vitamin E Deficiency
品牌名
Mvi Pediatric, Natafort
技术标识符
化学式
C
31
H
52
O
3
CAS 编号
52225-20-4
UNII ID
WR1WPI7EW8
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Formulation and delivery method to enhance antioxidant potency of Vitamin E
US 7012092 B2
申请人: RICH MEL
优先权: 2000
US
7 件公开
THROAT GARGLE TABLET AND METHOD OF USE THEREOF
US 2014294990 A1
申请人: O'CONNOR TIMOTHY P
优先权: 2013
US
WO
4 件公开
Anti-heat stress composition for pigs
CN 102641306 A
申请人: TIANJIN HUIRUI ANIMAL PHARMACEUTICAL CO LTD
优先权: 2011
CN
Method for preparing vitamin E ethyl acetate in one kettle way
CN 102336732 A
申请人: FUJIAN FUKANG PHARMACEUTICAL CO LTD
优先权: 2011
CN
Preparation method for dl-alpha tocopheryl acetate
CN 108203425 A
申请人: ZHEJIANG MED XINCHANG PHARM
优先权: 2016
CN
GASTRO-RESISTANT FOOD/PHARMACEUTICAL CAPSULE FOR TREATMENT OF INFLAMMATORY BOWEL DISEASES
EP 3741361 A1
申请人: P&P FARMA S R L
优先权: 2019
EP
Tea seed meal polysaccharide compound and application thereof to feeds and treatment of porcine reproductive and respiratory syndromes
CN 110637934 A
申请人: JIANGXI ZHONGCHENGREN MEDICINE CO LTD
优先权: 2019
CN
Traditional Chinese medicine composition for treating salpingitis and ovaritis of laying fowls and preparation method of traditional Chinese medicine composition
CN 112755066 A
申请人: LINKSOAR HEBEI BIO TECH CO LTD
优先权: 2021
CN
Formula for inhibiting cancer cell regeneration and repairing damaged tissue and preparation method
CN 116712466 A
申请人: ZHONGKE AEROSPACE TECH SHANDONG CO LTD
优先权: 2023
CN
Chia seed oil composition for beautifying hair of dogs and cats as well as preparation method and application of chia seed oil composition
CN 121668220 A
申请人: SHANGHAI JIAODA ONLLY CO LTD
优先权: 2025
CN
药物
反馈